{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial of IFx-Hu2.0 as An Adjunctive Therapy to Pembrolizumab in Checkpoint Inhibitor Na\u00efve Subjects with Advanced or Metastatic Merkel Cell Carcinoma","item":"https:\/\/www.regionalcancercare.org\/trials\/a-multicenter-randomized-double-blinded-placebo-controlled-trial-of-ifx-hu2-0-as-an-adjunctive-therapy-to-pembrolizumab-in-checkpoint-inhibitor-naive-subjects-with-advanced-or-metastatic-merkel-cel\/#breadcrumbitem"}]}